315 related articles for article (PubMed ID: 15567898)
61. [Study of the capillary microscopy changes in scleroderma and their association with organ disease, clinical manifestations and disease progression].
Simeón CP; Fonollosa V; Vilardell M; Armadans L; Lima J; Cuenca R; Solans R; Espinach J
Med Clin (Barc); 1991 Nov; 97(15):561-4. PubMed ID: 1805078
[TBL] [Abstract][Full Text] [Related]
62. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.
Otieno FG; Lopez AM; Jimenez SA; Gentiletti J; Artlett CM
Tissue Antigens; 2007 Jun; 69(6):583-91. PubMed ID: 17498268
[TBL] [Abstract][Full Text] [Related]
63. Macroangiopathy of the upper extremities in progressive systemic sclerosis.
Stücker M; Quinna S; Memmel U; Röchling A; Traupe M; Hoffmann K; Köster O; Altmeyer P
Eur J Med Res; 2000 Jul; 5(7):295-302. PubMed ID: 10903189
[TBL] [Abstract][Full Text] [Related]
64. Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon.
Beltrán E; Toll A; Pros A; Carbonell J; Pujol RM
Br J Dermatol; 2007 May; 156(5):892-8. PubMed ID: 17388920
[TBL] [Abstract][Full Text] [Related]
65. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients.
Sebastiani M; Manfredi A; Colaci M; D'amico R; Malagoli V; Giuggioli D; Ferri C
Arthritis Rheum; 2009 May; 61(5):688-94. PubMed ID: 19405007
[TBL] [Abstract][Full Text] [Related]
66. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.
Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R
Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303
[TBL] [Abstract][Full Text] [Related]
67. Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic Approaches.
Volkmann ER; Furst DE
Rheum Dis Clin North Am; 2015 Aug; 41(3):399-417. PubMed ID: 26210126
[TBL] [Abstract][Full Text] [Related]
68. Survival and organ involvement in patients with limited cutaneous systemic sclerosis and anti-topoisomerase-I antibodies: determined by skin subtype or auto-antibody subtype? A long-term follow-up study.
Kranenburg P; van den Hombergh WM; Knaapen-Hans HK; van den Hoogen FH; Fransen J; Vonk MC
Rheumatology (Oxford); 2016 Nov; 55(11):2001-2008. PubMed ID: 27520796
[TBL] [Abstract][Full Text] [Related]
69. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
[TBL] [Abstract][Full Text] [Related]
70. Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon.
Maricq HR; Weinberger AB; LeRoy EC
J Rheumatol; 1982; 9(2):289-91. PubMed ID: 7097688
[TBL] [Abstract][Full Text] [Related]
71. Late Nailfold Videocapillaroscopy Pattern Associated With Hand Calcinosis and Acro-Osteolysis in Systemic Sclerosis.
Morardet L; Avouac J; Sammour M; Baron M; Kahan A; Feydy A; Allanore Y
Arthritis Care Res (Hoboken); 2016 Mar; 68(3):366-73. PubMed ID: 26223810
[TBL] [Abstract][Full Text] [Related]
72. Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score.
Dziadzio M; Smith RE; Abraham DJ; Black CM; Denton CP
Rheumatology (Oxford); 2005 Dec; 44(12):1518-24. PubMed ID: 16159952
[TBL] [Abstract][Full Text] [Related]
73. Clinical diagnosis compared to classification criteria in in a cohort of 54 patients with systemic sclerosis and associated disorders.
Ziswiler HR; Urech R; Balmer J; Ostensen M; Mierau R; Villiger PM
Swiss Med Wkly; 2007 Oct; 137(41-42):586-90. PubMed ID: 17990152
[TBL] [Abstract][Full Text] [Related]
74. Increased serum soluble CD40 levels in patients with systemic sclerosis.
Komura K; Fujimoto M; Matsushita T; Yanaba K; Kodera M; Kawasuji A; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2007 Feb; 34(2):353-8. PubMed ID: 17295440
[TBL] [Abstract][Full Text] [Related]
75. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
[TBL] [Abstract][Full Text] [Related]
76. [Classification of microangiopathy in systemic sclerosis].
Alekperov RT
Ter Arkh; 2005; 77(5):52-6. PubMed ID: 15989004
[TBL] [Abstract][Full Text] [Related]
77. Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon.
Istok R; Czirják L; Lukác J; Stancíková M; Rovenský J
Rheumatology (Oxford); 2001 Feb; 40(2):140-6. PubMed ID: 11257149
[TBL] [Abstract][Full Text] [Related]
78. -238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis.
Tolusso B; Fabris M; Caporali R; Cuomo G; Isola M; Soldano F; Montecucco C; Valentini G; Ferraccioli G
Immunol Lett; 2005 Jan; 96(1):103-8. PubMed ID: 15585313
[TBL] [Abstract][Full Text] [Related]
79. Cutaneous Features, Autoantibody Profile, and Nailfold Capillaroscopy of Systemic Sclerosis: A Study of 60 Cases.
Dave J; Mahajan S; Khadilkar P; Pradhan V
J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355940
[TBL] [Abstract][Full Text] [Related]
80. [A case of systemic sclerosis in childhood complicated by severe digital ulcers].
Falcini F; Volpi M; Pierattelli M; Taccetti G; Pratesi G; Matucci Cerinich M
Pediatr Med Chir; 1984; 6(5):703-7. PubMed ID: 6535137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
